Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°ñ ´ë»ç ¾à¹° º¹¿ë ȯÀÚÀÇ MRONJ À§Çè ÀÎÀÚ·ÎÀÇ Implants

Dental Implants as Risk Factors for MRONJ in Patients Taking Bone Modifying Agents

´ëÇÑÄ¡°úÀÇ»çÇùȸÁö 2022³â 60±Ç 1È£ p.39 ~ 47
ÃÖÁ¤ÀÓ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖÁ¤ÀÓ ( Choi Jung-Lim ) - Dankook University Dental Hospital Department of Advanced General Dentistry

Abstract


As the age of patients requiring implant treatments increases, the number of patients taking more than one type of medicine due to underlying diseases increases. In particular, bone modifying agents such as bisphosphonate bring rare but potentially fatal osteonecrosis of the jaw (ONJ), so careful attention is needed before dental treatment. For patients receiving these medications, the outcome of implants and the incidence of implant related ONJ are still unclear, causing clinicians to hesitate to treat them. Therefore, in this article, we would like to discuss the dental implants as a risk factor for the occurrence of ONJ and discuss what clinicians should consider in implant treatment for patients taking bone modifying agents by reviewing previous literatures.

Å°¿öµå

BRONJ; MRONJ; Dental implants; Risk factor

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI